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ABSTRACT
Background: Interesterified (IE) fats are widely used in place of
trans fats; however, little is known about their metabolism.
Objectives: To test the impact of a commonly consumed IE
compared with a non-IE equivalent fat on in vivo postprandial and
in vitro lipid metabolism, compared with a reference oil [rapeseed
oil (RO)].
Methods: A double-blinded, 3-phase crossover, randomized con-
trolled trial was performed in healthy adults (n = 20) aged 45–
75 y. Postprandial plasma triacylglycerol and lipoprotein responses
(including stable isotope tracing) to a test meal (50 g fat) were
evaluated over 8 h. The test fats were IE 80:20 palm stearin/palm
kernel fat, an identical non-IE fat, and RO (control). In vitro,
mechanisms of digestion were explored using a dynamic gastric
model (DGM).
Results: Plasma triacylglycerol 8-h incremental area under the
curves were lower following non-IE compared with RO [–1.7
mmol/L·h (95% CI: –3.3, –0.0)], but there were no differences
between IE and RO or IE and non-IE. LDL particles were smaller
following IE and non-IE compared with RO (P = 0.005). Extra
extra large, extra large, and large VLDL particle concentrations
were higher following IE and non-IE compared with RO at 6–8
h (P < 0.05). No differences in the appearance of [13C]palmitic
acid in plasma triacylglycerol were observed between IE and non-
IE fats. DGM revealed differences in phase separation of the IE
and non-IE meals and delayed release of SFAs compared with
RO.
Conclusions: Interesterification did not modify fat digestion,
postprandial lipemia, or lipid metabolism measured by stable isotope
and DGM analysis. Despite the lower lipemia following the SFA-rich
fats, increased proatherogenic large triacylglycerol-rich lipoprotein
remnant and small LDL particles following the SFA-rich fats relative
to RO adds a new postprandial dimension to the mechanistic evidence
linking SFAs to cardiovascular disease risk. Am J Clin Nutr
2021;00:1–11.
Keywords: lipid, interesterification, palmitic acid, rapeseed oil,
metabolism, healthy adults, postprandial lipemia
Introduction
Interesterification is a process extensively used by the food
industry to produce solid fats with suitable functionality for di-
verse applications, including bakery, spreads, and confectionery
products. Interesterification involves the chemical or enzymatic
redistribution of fatty acids across the sn-1, sn-2, and sn-3
positions on the glycerol backbones of triacylglycerols (TAG) (1).
This process is typically used in conjunction with fractionation
and full hydrogenation to form a trans-free “hard stock.” The
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resulting hard stock is blended in different proportions with
vegetable oil [typically rapeseed oil (RO)] to produce fats with
desirable functional properties. Subsequently, interesterified (IE)
fats 1) are alternatives to harmful trans fatty acid–containing
partially hydrogenated fats, 2) are lower in saturated fat compared
with traditional fats (e.g., butter), and 3) give the food industry
greater control over the physical and organoleptic properties of
the fat (1). Despite their widespread use, little is known about how
IE fats are metabolized by the body and their subsequent health
effects, with most previous work focusing on IE fats, which are
not commonly used commercially [previously discussed (1)].
Many of the chronic health effects of dietary fats are under-
pinned by acutely changing lipid-induced circulating metabo-
lites. Following fat consumption, there is an acute elevation in
circulating TAG [an independent risk factor for cardiovascular
disease (CVD)] (2–4), which remain elevated for ∼8 h. Alongside
this, there is a perturbation in circulating atherogenic lipoproteins
(5) and increases in circulating inflammatory, oxidative stress,
and hemostatic measures, affecting endothelial function (6) and
CVD risk (7). Given that we consume multiple meals throughout
the day, we spend the majority of our day in a postprandial state.
Therefore, determining an individual’s postprandial response to
different dietary fats is a powerful tool for understanding their
chronic health effects.
We (8–12) and others (13, 14) have previously shown
that interesterification influences postprandial fat handling and
lipemic responses, reviewed elsewhere (15, 16). However,
because interesterification simultaneously changes the solid fat
content and increases the proportion of SFAs in the sn-2 position,
it is unclear whether observed differences in postprandial lipemia
are due to changes in physical properties (solid fat profile) or
positional composition (sn- positional composition), which may
affect rates of digestion and metabolism (15).
Therefore, the purpose of this study was to 1) investigate the
impact of a commonly consumed IE fat compared with non-
IE fat and a reference high-MUFA oil on postprandial lipid
metabolism in a randomized controlled trial (in vivo) and 2) use a
dynamic gastric model (DGM) of digestion to identify potential
mechanisms underpinning in vivo observations (in vitro). We
hypothesized that interesterification would increase postprandial
lipemia over 8 h possibly due to alterations in the physical
properties of the fat.
Methods
Participants
Ethical approval for the Inter-Met study was obtained from
King’s College London Research Ethics Committee (HR-
16/17-4397), and written informed consent was provided by
participants. The study was registered at clinicaltrials.gov as
NCT03191513 and conducted in accordance with the ethical
standards laid down in the 1964 Declaration of Helsinki and
its later amendments. Healthy adult men and women (aged
45–75 y) were recruited via advertisements at King’s College
London and the surrounding area between June and November
2017. Interested participants were sent an initial screening
questionnaire, and if deemed eligible from this, they were invited
for a screening visit at the Metabolic Research Unit (MRU) at
the Department of Nutritional Sciences, King’s College London,
following an overnight fast (12 h). Their weight, height, waist and
hip circumference, percentage body fat, seated blood pressure,
glucose, insulin, liver function, and lipid profile were measured as
outlined previously (11). Participants were requested to complete
a 3-d diet diary to assess their habitual nutritional intakes (2
weekdays and 1 weekend day) using dietary assessment software
(Nutritics Ltd). Exclusion criteria were as follows: medical
history of myocardial infarction, angina, thrombosis, stroke,
cancer, liver or bowel disease or diabetes, BMI (in kg/m2) <20
or >35, fasting plasma cholesterol ≥7.5 mmol/L, TAG >3
mmol/L or glucose >7 mmol/L, blood pressure ≥140/90 mmHg,
current use of antihypertensive or lipid-lowering medications,
alcohol intake exceeding a moderate intake (>224 g/wk), and
current cigarette smoker. The study was powered for 20 people
(10 men and 10 women separately) to complete, to detect a
mean difference in plasma TAG incremental area under the curve
(iAUC) of 40 mmol/L/min with an SD of differences of 32
mmol/L/min, at 95%, P < 0.05, and a mean difference of 0.30
mmol/L in peak concentrations with an SD of differences of 0.33
mmol/L, at 80%, P < 0.05, using previous data from our group
(12).
Randomized controlled trial design and test fats
A randomized, double-blind, 3-phase crossover design was
used to compare test meals differing in the type of fat, with a
minimum 1-wk washout period. Each test meal consisted of a
muffin and a milkshake containing 3.75 MJ (896.5 kcal), 16 g
protein (7% energy), 88 g carbohydrate (39% energy), and 50 g
test fat (54% energy); all meals were similar in appearance and
taste. A subgroup (n = 9) of the participants received muffins
with 75 mg [1,1,1]-13C glyceryl tripalmitate (Cambridge Isotope
Laboratories); these participants had a minimum 4-wk washout
between visits.
Outcome variables.
The primary outcome was iAUC0–8 for TAG with other TAG
parameters as secondary outcomes. Other secondary outcomes
included plasma TAG fraction fatty acid composition and
nonesterified fatty acids (NEFAs), chylomicron TAG concentra-
tion apolipoprotein B48 (apoB48), 13C TAG, breath CO2 13C,
lipoprotein particle size, and number.
The test fats were non-IE palm stearin (PSt)/palm kernel (PK),
IE PSt/PK (blended at a ratio of 80:20 PSt/PK, made from the
same batch of oil), and RO (control) (all provided by ADM
Speciality Oils & Fats Ltd). Both the non-IE and the IE fat
blends had a similar fatty acid composition, but the proportions
of palmitic acid in the sn-2 position were 33 mol% and 53
mol%, respectively (Table 1). Measurement of the solid fat
content by NMR (European laboratories of ADM Hamburg AG)
of the non-IE and IE gave values shown in Table 1; notably
(close to body temperature), they were 25.8% and 22.7% at
35◦C and 19.5% and 11.5% at 40◦C, respectively. Participants
consumed the test meals in a random order determined by
computer randomization allocated sequentially by a technician
independent of the study; treatment allocation was blinded from
the study participants and investigators. On the day preceding
each test meal, participants were instructed not to participate
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TABLE 1 Fatty acid composition of the experimental fats (wt%)1
Fatty acid Non-IE2 IE2 Rapeseed oil
12:0 8.7 8.5 0.0
14:0 3.9 3.8 0.0
16:0 49.6 48.8 6.8
18:0 4.5 4.5 3.0
18:1n–9 cis 25.5 26.6 62.0
18:2n–6 cis 5.3 5.4 18.6
18:3n–3 cis 0.1 0.1 9.7
Solid fat content at 10◦C, % 74.0 79.3 0.0
Solid fat content at 20◦C, % 54.6 59.7 0.0
Solid fat content at 25◦C, % 44.2 48.4 0.0
Solid fat content at 30◦C, % 34.0 35.3 0.0
Solid fat content at 35◦C, % 25.8 22.7 0.0
Solid fat content at 40◦C, % 19.5 11.5 0.0
1Data are presented as percent base on total weight.
2An 80:20 (%) blend of palm stearin/palm kernel.
high in fat. They were provided with a standardized low-fat
meal (containing <20 g fat) to consume as their evening meal
before 22:00. Participants attended the MRU between 08:00 and
10:00 the following morning. A cannula was inserted into the
forearm (antecubital vein), baseline samples were taken, and
the test meal was consumed within 10 min. Additional venous
blood samples were collected at hourly intervals until 8 h after
meal consumption. Participants had access to water to drink at
regular intervals throughout the study day. Following the 3-h
blood sample, participants consumed a fat-free lunch meal of 1.7
MJ consisting of 190 g fat-free yogurt and a banana, as used in
our previous studies to make the procedure tolerable (11).
Analytical methods
Test fat analysis.
The fatty acid composition of the test fats and positional
composition were determined as previously described (8). The
composition of the test fats is shown in Table 1.
Circulating lipid analysis.
TAG, NEFA, and fatty acid composition was performed
on blood samples taken hourly between 0 and 8 h. NEFA
(WAKO NEFA-HR) and TAG (Roche Diagnostics Limited)
concentrations were analyzed in plasma using enzymatic assays
on an ILAB-650 clinical chemistry analyzer (Instrumentation
Laboratories), with interassay CVs of 2.3% and 2.4%, re-
spectively. Plasma TAG fraction fatty acids were analyzed by
gas–liquid chromatography, as previously described (17). Total
lipoprotein profiles (size and particle number) were determined
at 0, 2, 4, 5, 6, and 8 h by NMR performed on serum by
Nightingale Health (18), using the 2016 panel. Chylomicrons
were separated from plasma at 2, 4, and 6 h after baseline
by ultracentrifugation. ApoB48 analysis was conducted by
immunoassay (Affinity Biomarker Labs), representing apoB48
concentrations in these chylomicron fractions. Lipids were also
extracted from the chylomicrons and the TAG fraction isolated
by thin-layer chromatography (TLC). Sn-2 fatty acid composition
of the test fat was analyzed by gas chromatography on fatty acid
methyl esters (FAMEs) as outlined previously (8).
Samples for all analyses were collected into EDTA tubes,
other than for lipoprotein profiles, which were collected in serum
separating tubes. Blood was centrifuged, and resulting plasma or
serum was stored at –80◦C for later analysis.
Stable isotope analysis
TAG fractions were isolated from plasma by TLC, and TAG
FAME concentrations were analyzed by gas chromatography–
isotope ratio mass spectrometry (GC-IRMS) to determine 13C
enrichment over the postprandial period. Plasma fatty acid and
breath samples were analyzed for 13C/12C ratio by IRMS (Delta
V Plus; Thermo Scientific) and expressed as δ13C in units of ‰
or per mil, calibrated using a FAME fatty acid standard (Indiana
University, Bloomington) that had been normalized to Vienna Pee
Dee Belemnite (VPDB). The isotopic enrichment of plasma and
breath samples was expressed as percent dose recovered (PDR)
for plasma (PDRPlasma) and breath CO2 (PDRBreath) (18). Briefly,
the 13C/12C ratio of both the plasma and breath samples was
expressed as the delta (δ13C; in units of ‰ or per mil) compared
with the international standard VPDB, with a 13C/12C ratio of
0.0112372. The 13C enrichment in the plasma and breath samples
was calculated as
δ13C = RS − RPDB
RPDB
× 1000, (1)
where RS is the 13C/12C ratio of the sample, and RPDB is the
13C/12C ratio of VPDB.
Using the δ13C, we then calculated the atom percent excess
of the tracer and further calculated the PDR of the tracer from
β-oxidation (19, 20). Briefly, PDRBreath was calculated using the
following formula:
PDRBreath=
APE (atom percent excess) × VCO2
mmol 13C administered
× 1000, (2)
where VCO2 was calculated by multiplying the CO2 production
constant (300 mmol/h) by body surface area (19). The PDRPlasma
(13C recovery in plasma fatty acids) was calculated as the absolute
amount of [13C]palmitic acid recovered in the plasma TAG pool






/ajcn/advance-article/doi/10.1093/ajcn/nqaa413/6155854 by guest on 16 M
arch 2021
4 Mills et al.
were used to determine the PDRPlasma:
Dose (mg) 13C recovered = APE × fatty acid pool size (mg)
× molecular weight of carbons
in palmitic acid (3)
The fatty acid pool size was calculated according to an
estimated plasma volume of 4.5% of body weight and multiplied
by the fatty acid concentration and the molecular weight of
the carbons present in the palmitic acid. The PDRPlasma was
calculated as follows:
PDRPlasma =
Dose (mg) 13C recovered
Dose (mg) 13C administered
× 100%, (4)
where the dose 13C recovered was derived from the previous
equation, and the dose 13C administered was the proportion of the
75 mg [1,1,1]-13C glyceryl tripalmitin, which was [13C]palmitic
acid.
Simulated gastric digestion
The mechanisms of gastric emptying of IE/non-IE fats from
the stomach were investigated in vitro. Non-IE fat, IE fat, and
RO test meals used in the in vivo study were replicated and
tested using a simulated oral phase (21) and gastric conditions
by DGM, which is a fully dynamic, physical, and biochemical
simulation of the human stomach (22). The DGM incorporates
the inhomogeneous gastric mixing, antral shearing, and rate
of delivery to the duodenum, with addition of gastric acid
and enzymes in a normal physiologic range and flow rates
modified in real time. Based on eco planar MRI and human
studies data on nasogastric and nasoduodenal aspiration (23–
26), the DGM provides a realistic tool for the simulation of
human gastric digestion. For the oral phase, in duplicate, 150-
g muffins, providing 50 g fat per test meal, were microwaved
at full power for 30 s and then passed through a meat mincer
(Lakeland) to simulate mechanical oral breakdown, producing
chewed particles ≤3.0 mm. Simulated salivary fluid (SSF; 75
mL) at pH 6.9 (0.15 M NaCl, 3 mM urea) and human salivary
amylase (2700 U) dissolved in SSF (1 mL) were added to the
minced muffins, as previously described by Mandalari et al. (21).
Chewed muffins were mixed with a homemade milkshake freshly
prepared and containing skimmed milk (220 mL), strawberry
milkshake powder (Nesquik; Nestlé) (15 g), and caster sugar
(2 g).
The chewed materials were transferred to the DGM, where
they underwent physical (massage) and biochemical processing
(gradual reduction of pH and proteolysis by pepsin). For the
gastric phase, a suspension of single-shelled lecithin liposomes
prepared as previously described (21) was added to a gastric
enzyme solution [0.15 mM NaCl, 2000 U/mL porcine pepsin, 60
U/mL gastric lipase (analogue of fungal origin; Amano Enzyme)]
at a final concentration of 0.127 mM phosphatidylcholine [egg
L-α-phosphatidylcholine (lecithin grade 1, 99% purity); Lipid
Products]. Gastric digestions were carried out on the chewed
muffin samples (520 g) in the presence of 20 mL priming acid
(0.1 M HCl, 0.08 M NaCl, 0.03 mM CaCl2, 0.9 mM NaH2PO4).
Simulated gastric acid (0.2 M HCl, 0.08 M NaCl, 0.03 mM
CaCl2, 0.9 mM NaH2PO4) and gastric enzyme solution were
mechanically secreted into the DGM throughout the digestion.
Nine ∼61-g samples were emptied from the DGM at 14, 28, 42,
56, 70, 84, 98, 112, and 126 min. Gastric emptying rates were
determined by the amount of fat and the fatty acid profiles of the
fat emptied from the DGM over time.
Statistics
Statistical analysis was performed using IBM SPSS Statistics
version 25.0. For each of the analyses described below, the
assumptions of normality and homogeneity of variance were
assessed, and none of the outcomes were deemed necessary to
require transformation.
The iAUC was calculated using the trapezoidal rule. The
iAUC, Cmax, and time point data following each treatment were
analyzed using a linear mixed model. Terms in the model
included treatment group, time point, period, and treatment
× period as fixed effects (and treatment × time for time
point analysis), participant as a random effect, and baseline
values as covariates. For plasma TAG and lipoprotein particle
concentrations/size, further analysis was conducted with sex
and treatment × sex as fixed effects. Participants who did not
complete all 3 study periods or where there were missing data
at individual time points but data from at least one of the study
periods or other time points in all study periods were included
in the analysis by including participant as a random effect in
the analysis. For the calculation of iAUC, if one value was
missing over the assessment period, the AUC was generated by
imputation using the average of the values available either side
of the missing time point (there were 3 missing TAG data points
in total). If there was >1 missing value or either of the start
or end values were missing, no iAUC was calculated for that
period for that participant. For all tests, the significance level was
set at P < 0.05 (2-tailed). Post hoc analyses were made using
Bonferroni adjustment for multiple comparisons.
Results
Participants
Twenty participants completed the study (10 men and 10
women); details of the flow of participants through the study are
shown in Supplementary Figure 1, and baseline characteristics
of the study participants are in Table 2.
Postprandial lipemia
There were no differences in postprandial plasma TAG
concentrations between IE and non-IE fats (Figure 1), measured
by iAUC(0–8 h), iAUC(0–4 h), Cmax, and Tmax (Table 3). However, in
comparison with the RO (high-MUFA control oil), postprandial
plasma TAG concentrations following both IE and non-IE
were lower (treatment effect P = 0.0008 and treatment ×
time interaction P = 0.007). Relative to RO, iAUC(0–4 h) was
significantly lower following both IE (P = 0.003) and non-IE
fats (P = 0.0003), whereas iAUC(0–8 h) was significantly lower
following non-IE only (P = 0.043). In addition, there was a
trend for a higher Cmax following RO compared with non-IE
(P = 0.058). Analysis by sex did not reveal any significant
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TABLE 2 Baseline characteristics of trial participants1
Characteristic Total (n = 20) Women (n = 10) Men (n = 10)
Age, y 58.5 ± 6.4 59.3 ± 6.4 57.7 ± 6.8
Height, m 1.72 ± 0.12 1.61 ± 0.05 1.82 ± 0.05
Weight, kg 77.2 ± 14.9 67.8 ± 12.0 86.6 ± 11.3
BMI, kg/m2 26.2 ± 3.8 26.0 ± 4.2 26.3 ± 3.6
Hip/waist ratio 0.88 ± 0.06 0.85 ± 0.05 0.91 ± 0.05
Systolic BP, mmHg 116.2 ± 11.3 113.6 ± 14.5 119.2 ± 5.5
Diastolic BP, mmHg 76.6 ± 9.5 72.8 ± 10.4 80.4 ± 7.2
Plasma glucose, mmol/L 5.16 ± 0.48 5.25 ± 0.52 5.06 ± 0.45
Serum total cholesterol, mmol/L 5.61 ± 0.7 5.79 ± 0.33 5.42 ± 0.92
Serum LDL cholesterol, mmol/L 3.47 ± 0.62 3.57 ± 0.31 3.36 ± 0.84
Serum HDL cholesterol, mmol/L 1.60 ± 0.33 1.62 ± 0.31 1.57 ± 3.36
Serum triglycerides, mmol/L 1.18 ± 0.47 1.31 ± 0.56 1.05 ± 0.34
Total/HDL cholesterol 3.63 ± 0.70 3.71 ± 0.73 3.55 ± 0.70
Energy MJ/d 7.8 ± 1.9 7.3 ± 1.4 8.4 ± 2.2
Protein, % energy 19.1 ± 4.0 18.6 ± 3.4 19.7 ± 4.6
Carbohydrate, % energy 47.1 ± 10.0 45.9 ± 8.2 48.5 ± 10.9
Fat, % energy 32.1 ± 8.1 34.6 ± 5.5 29.4 ± 9.6
1Data are means ± SDs. BP, blood pressure.
treatment × sex interactions. There were no treatment effects on
postprandial NEFA concentrations (Supplementary Figure 2).
Labeled palmitic acid appearance in plasma triacylglycerol
fraction and breath
No treatment differences were observed in the PDRplasma
for [13C]palmitic acid (iAUC) when comparing IE and non-IE
FIGURE 1 Plasma triacyglycerol (TAG) concentrations following a test
meal containing 50 g interesterified (IE) palm stearin/palm kernel (PSt/PK)
fat compared with a non-IE equivalent, relative to a reference rapeseed oil
(RO). Data are mean (SEM), n = 20. Comparison of IE PSt/PK and non-
IE PSt/PK by linear mixed-model analysis (dependent variable change from
baseline, fixed factors of treatment, time, period, treatment × time interaction,
treatment × period interaction; random effect participant; covariate baseline
TAG concentrations) showed no significant treatment or treatment × time
effects. Comparison of all treatments showed a significant treatment effect
(P = 0.0008), treatment × time effect (P = 0.007), and treatment × period
effect (P = 0.037). Post hoc analysis of time point differences with Bonferroni
adjustment showed significant differences between both IE and non-IE fats
compared with RO at 2 and 3 h (∗IE compared with RO P = 0.004 and non-
IE compared with RO P = 0.0002, ∗∗IE compared with RO P = 0.0006 and
non-IE compared with RO P = 0.0008).
fats (treatment effect P = 0.155; mean difference IE – non-
IE: 0.019%; 95% CI: –0.007, 0.045) (Figure 2A). There was a
significant main effect of meal for labeled palmitic acid oxidation
as measured by PDRBreath CO2 (iAUC), with a reduction in the
appearance of breath 13C following IE fat compared with non-IE
fat (Figure 2B: treatment effect P = 0.017; mean difference IE –
non-IE: –0.19%; 95% CI: –0.34, –0.04).
Postprandial lipoprotein particles
Postprandial lipoprotein subfraction particle concentrations
and size are presented in Table 4. For comparisons between IE
and non-IE fats, extra extra large (XXL)–VLDL/chylomicron
(with average diameter >75 nm) particle concentrations were
significantly higher following IE compared with non-IE (post
hoc pairwise treatment effect P = 0.023), but there were no
Bonferroni-adjusted time point–specific significant differences
between the 2 fats. Otherwise, no differences between IE and non-
IE were observed.
There were a number of differences between IE/non-IE fats
and RO. LDL size was significantly lower following IE and
non-IE fats relative to RO (P = 0.005). VLDL size was
reduced by palmitic acid–rich fats at 2 h relative to RO (IE,
P = 0.008; non-IE, P = 0.013) and increased in the late
postprandial period compared with RO (6 h IE, P = 0.054;
6 h non-IE, P = 0.012; 8 h IE, P = 0.007; 8 h non-
IE, P = 0.026). There were significantly lower (2 h) and
higher (6–8 h) concentrations of XXL-VLDL, extra large (XL)–
VLDL, and large-VLDL particles following both IE and non-
IE fats compared with RO (Table 4), whereas there were no
treatment effects for medium-VLDL and small-VLDL particle
concentrations. Analysis by sex did not reveal any significant
differences in postprandial lipoprotein particle concentrations







/ajcn/advance-article/doi/10.1093/ajcn/nqaa413/6155854 by guest on 16 M
arch 2021












































































































































































































































































































































































































































































































































































































































































































































FIGURE 2 The effect of an interesterified (IE) palm stearin/palm kernel
(PSt/PK) fat on postprandial [13C]palmitic acid recovery in (A) plasma
triacyglycerol (TAG) palmitic acid and (B) CO2 from breath. Data are
expressed as mean (SEM), n = 9, hourly percent dose recovery (PDR) of the
total [13C] palmitic acid consumed as 75 mg [1,1,1]-13C glyceryl tripalmitin
blended in the test fats used in the study meals. No differences were observed
in (A) PDRPlasma [incremental area under the curve (iAUC)] between IE and
non-IE fats over the postprandial period. Non-IE (B) PDRBreath (iAUC) was
higher than IE over the postprandial period (P = 0.017). Data were analyzed
using a linear mixed model.
Chylomicron fraction apoB48 concentrations
There were no effects of meal type on chylomicron fraction
apoB48 concentrations (Figure 3A). There were no differences
in postprandial TAG/apoB48 molar ratio (chylomicron size)
between IE and non-IE fats, but ratios of TAG molecules to
apoB48 molecules were significantly lower following both IE
(P = 0.00006) and non-IE (P = 0.00002) fats compared with
RO, with post hoc time point analysis showing differences
at 2 h only (Figure 3B). This indicates larger chylomicrons
following RO compared with the palm-based fats in the early
postprandial period. There were no sex effects or treatment × sex
interactions.
Plasma triacylglycerol fatty acid composition
There was a very small but significant difference between IE
and non-IE fats for plasma TAG fraction palmitic acid (16:0),
with higher concentrations of plasma 16:0 following IE compared
with the non-IE equivalent (treatment effect P = 0.011), with
no treatment × time interaction (Supplementary Figure 3A).
Post hoc comparisons at individual time points showed that
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A
B
FIGURE 3 The effect of an interesterified (IE) palm stearin/palm kernel
(PSt/PK) fat on postprandial (A) apolipoprotein B48 (apoB48) concentrations
and (B) triacyglycerol (TAG)/apoB48 molar ratio relative to a non-IE
equivalent and a reference rapeseed oil (RO). Data are mean (SEM), n = 20.
Data were analyzed using a linear mixed model (dependent variable natural
log of triacylglycerol; LnTAG /apoB48 ratio; fixed factors of treatment, time,
period, treatment × period, treatment × time; and participant as a random
effect). Post hoc analysis of time point differences with Bonferroni adjustment
showed significant differences between both IE and non-IE fats compared
with RO at 2 h: ∗IE compared with RO P = 0.002, non-IE compared with RO
P = 0.004.
(mean difference IE – non-IE: 0.66 mg/L; 95% CI: 0.15, 1.19;
P = 0.011). As expected, there were significant differences
between both fats compared with RO for 16:0 (treatment effect
P < 0.001), 16:1n–9 (P < 0.001, data not shown), 18:0
(P < 0.001), 18:1n–9 (P < 0.001), and 18:2 (P < 0.001)
(Supplementary Figure 3A–D).
In vitro analysis: Rate of delivery and free fatty acids
production during simulated gastric digestion
There was clear phase separation observed in gastric samples
of IE and non-IE (see Supplementary Figure 4). The profile of
free fatty acids (FFAs) released at each time point during gastric
digestion is shown in Figure 4. The trend followed the overall fat
composition of IE, non-IE, and RO, except for lauric acid (C12),
in which a more consistent rate of emptying was detected, with a
slight dilution over time. Since lauric acid is not a RO fatty acid,
and the concentrations are consistent between all 3 samples, it is




FIGURE 4 Free fatty acid and total fat concentrations of samples
emptied from the dynamic gastric model during simulated gastric digestion at
specific time points (14 to 126 min) for muffins made from (A) interesterified
palm stearin/palm kernel (IE PSt/PK), (B) non-IE PSt/PK, and (C) rapeseed
oil (RO).
from the lecithin used to stabilize the milkshake powder. For IE
and non-IE fats, the total FFA content emptied from the DGM
was very low in the early time points (∼10 mg/g, compared with
∼100 mg/g for RO) and then increased toward the final stages,
consistent with the observed creaming effect (Supplementary
Figure 4) delaying the emptying of the fat from the DGM. For
the RO sample, the FFA concentrations were more consistent,
gradually decreasing across the time points. For IE and non-IE,
C12 was the most abundant FFA emptied in the first 2 time points,
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profile was more similar to the other fats. A linear relation was
found plotting the FFA profiles against the total fat emptied (apart
from C12), suggesting that each FFA released followed the trend
of the total fat (results not shown).
Discussion
In light of the widespread use of IE fats, the aim of the current
study was to investigate the impact of a widely used IE fat on
postprandial metabolism compared with its non-IE counterpart
and a high MUFA control oil. Contrary to our hypothesis, we
did not observe an effect of interesterification on postprandial
lipemia. However, a novel finding was the unfavorable pattern of
late postprandial lipoprotein particles elicited following the SFA-
rich fats (IE and non-IE fats) compared with the MUFA-rich oil
(RO).
In contrast to our current findings, we previously reported a
greater postprandial lipemia following the interesterification of
PSt/PK (80:20) compared with its non-IE counterpart in the first
0–4 h (12). We had proposed that the higher postprandial response
following the IE fat, in the absence of differences in solid fat
at body temperature (both between 22% and 25%), was due to
the higher proportion of palmitic acid in the sn-2 position of the
IE fat (53 mol%) compared with the non-IE fat (33 mol%), as
previously reported in animal and human infant studies (15, 27).
In partial support of the theory that digestion and absorption of
SFAs are superior when present in the sn-2 position, we observed
a slightly greater palmitic acid concentration in the plasma TAG
fraction following IE fat (higher sn-2 SFA) compared with non-
IE fat (lower sn-2 SFA) (Supplementary Figure 3A). However,
this small difference in plasma TAG fraction concentrations
did not extend to differences in lipemia as measured by total
plasma TAG, the appearance of [13C]palmitic acid in plasma, or
gastric emptying rates measured in vitro. A possible explanation
for in vivo differences between studies is the differences in
characteristics of the study populations. In the current study,
the average age was 58 y compared with 20 y in the previous
study using the same test meal challenge (nutrient composition)
and same test fats (12). Postprandial lipemia increases with age
(28) and metabolic flexibility reduces with age (e.g., reduced
insulin sensitivity) (29). Therefore, the lack of difference between
IE and non-IE fats in the current study may be due to a less
“efficient” metabolic response, masking any subtle differences
in metabolism elicited by differences in the sn-2 positional
composition of the test fats.
Interestingly, both palmitic acid–rich fats resulted in a lower
lipemia compared with the high-MUFA oil, in agreement with
our previous studies (10, 11). This may be due to the difference
in solid fat content at body temperature between fats (∼25%
difference), in agreement with previous work showing that
solid fat attenuates the postprandial lipemic response (11).
Alternatively, it may be a consequence of the larger chylomicrons
produced following MUFA-rich oils compared with SFA-rich
fats, which are cleared from the circulation more rapidly than
smaller chylomicron particles (30) and/or differential effects of
SFA- compared with MUFA-rich fats on gastric emptying (31).
Indeed, in the current study, the palmitic acid–rich fats resulted in
smaller chylomicron particles postprandially compared with the
MUFA-rich oil, as measured by the lower TAG/apoB48 ratio. In
addition, in line with the more pronounced attenuation in lipemia
in the early phase (0–4 h), chylomicron particle concentrations
(the XXL-VLDL particles measured by NMR; >75 nm) were
lower during the early postprandial phase (2 h), and both XXL-
VLDL particles and VLDL particle size were higher during the
late phase (6–8 h) following the palmitic acid–rich fats compared
with the MUFA-rich oil, indicating a more rapid removal of
MUFA-containing chylomicrons. Furthermore, in vitro gastric
digestion demonstrated phase separation for the palmitic acid–
rich fat muffins, which is likely to be due to their high solid fat
content, resulting in a change in buoyancy and delayed gastric
emptying of the fats that had creamed to the top of the digesta.
Indeed, the work by Thilakarathna et al. (32) demonstrates that
there is a complex interplay between the physical state of dietary
fat and its colloidal properties, which impact digestion and
lipolysis. Taken together with the differences in lipoproteins, this
suggests that both delayed gastric emptying of the higher melting
point SFA-rich fats and more rapid removal of the MUFA-rich
oil may account for the observed differences in postprandial
lipemia.
A novel finding of the current study was the unfavorable
lipoprotein profile, despite the lower lipemic response following
the palmitic acid–rich fats compared with the MUFA-rich
oil, namely, smaller LDL particle size and higher XL-VLDL
particle concentrations at 6–8 h. XL-VLDL has a mean size
of 64 nm and, unlike the larger XXL-VLDL (representative
of chylomicrons postprandially), is thus reflective of TAG-rich
lipoprotein (TRL; chylomicrons and VLDL) remnant particles
(33), which are associated with an increased risk of CVD
(34, 35). The importance of postprandial lipemia in relation to
CVD risk is gaining recognition (36), and large epidemiologic
studies have shown that elevated nonfasting (postprandial) TAG
is an independent risk factor for CVD in part mediated by
the generation of atherogenic lipoproteins in the postprandial
phase [reviewed elsewhere (7)]. During the postprandial phase,
lipoprotein remodeling occurs, mediated by cholesteryl ester
transfer protein, resulting in the reciprocal exchange of TAG and
cholesterol between TRL and HDL and LDL. If postprandial
lipemia is sustained over a prolonged period of time, this
reciprocal exchange is enhanced, resulting in TAG-enriched LDL
and HDL particles and cholesterol-enriched remnant TRL, which
are atherogenic (37). Furthermore, studies have found that the
concentration of lipemia is associated with the extent of this
lipoprotein remodeling (38). The more favorable lipoprotein
profile observed after the MUFA-rich oil, despite the higher
concentration of lipemia, may explain the association of dietary
MUFA with reduced CVD risk and inform recent debates
regarding the relevance of postprandial lipemia and CVD risk
(39). The adverse lipoprotein profile observed following the
palmitic acid–rich fats therefore adds to the body of mechanistic
evidence relating to the adverse effect of SFA-rich fats on
health (40) and highlights the importance of looking beyond the
traditionally measured postprandial TAG features when exploring
postprandial lipid associations with disease (41).
Although the lipemic responses between the IE and non-IE
fats did not differ, there were small differences in lipoprotein
particle numbers and breath 13C between the IE and non-IE fats,
namely, higher XXL-VLDL particles and lower breath 13C in the
postprandial period following IE consumption. Further studies
are required to understand the XXL-VLDL particle concentration
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breath 13C was an unexpected finding, suggesting a difference
in the availability of palmitic acid for oxidation between the IE
and non-IE meals. However, the 13C label was incorporated into
the fat as tripalmitin; palmitic acid intrinsic to the IE and non-IE
TAG was not labeled. Without an understanding of the fate of the
tracer at the TAG resynthesis/chylomicron assembly stage in the
enterocyte, any interpretation of these effects on the appearance
of 13C in breath can only be speculative.
There were significant treatment × period interactions for the
change from baseline in plasma TAG and also for large-HDL-P
(particles), medium-HDL-P, and small-VLDL-P concentrations
and HDL size. However, there were no treatment × period
interactions for the primary outcome (8-h iAUC for plasma TAG)
or other summary measures of postprandial lipemia, suggesting
that this did not represent a carryover effect. Furthermore, the
possibility of a 7-d carryover effect is implausible for a single
high-fat meal in which the outcomes of interest are only expected
to change during the postprandial period.
Conclusion
In conclusion, the process of interesterification did not modify
postprandial lipemia. However, the palmitic acid–rich fats, irre-
spective of interesterification, resulted in an attenuated lipemic
response compared with a MUFA-rich oil, which, in part, may
be due to delayed gastric emptying or altered chylomicron size
and composition. The greater preponderance of proatherogenic
large TRL remnant particles and small LDL particles in the late
postprandial phase following the palmitic acid–rich fats relative
to the MUFA-rich oil adds a new postprandial dimension to the
body of mechanistic evidence linking SFA to increased risk of
CVD and demonstrates the importance of looking beyond TAG
when exploring postprandial lipid-mediated associations with
CVD.
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